I am a dedicated consultant, researcher, and scholar who is passionate about making the world a better, healthier place, particularly for those who are the most different and the most vulnerable in organizations, in communities, and societies. Specifically, I leverage my extensive education, experience, and expertise to help biotechnology, healthcare, medical, pharmaceutical, and technology companies’ and increase their positive impact in health and medicine, as well as humanity more broadly. As core to this, I actively engage in consulting, publishing, speaking, and thought-leadership on the key HR, operational, organizational, and strategic dimensions of diversity, inclusion, and engagement.
Dr. James J. Gillespie, PhD, JD, MPA, is a consultant and scholar in the advanced application of diversity, inclusion and engagement to address challenges and opportunities for biopharmaceutical, healthcare, medical, and technology companies. He is co-founder of the “Diversity, Inclusion, and Health Equity Symposium”, the leading annual event focused on D&I for the global biopharmaceutical sector. Dr. Gillespie’s research has appeared in numerous academic journals and industry periodicals. He recently authored “Attaining gender parity: Diversity 5.0 and 10 best practices for global health care organizations” in The Health Care Manager and “Diversity, inclusion, and precision medicine in clinical oncology” in Frontiers in Oncology. Dr. Gillespie has also published in Academy of Management Review, American Behavioral Scientist, European Journal of Social Psychology, Harvard Business Review, and Strategic Management Journal. His education includes Northwestern University Kellogg School of Management, M.A., Ph.D.; Harvard University School of Law, J.D.; Princeton University Woodrow Wilson School of Public Policy, M.P.A.; Massachusetts Institute of Technology, B.S.; Carnegie Mellon University Heinz School; and Rand Graduate School. In addition to his work at Kaleidoscope Group, Dr. Gillespie serves on the Board of Directors at the Center for Healthcare Innovation in Chicago IL and as a Project Director at Stanford University School of Medicine in Palo Alto, CA.
